PvP Biologics

Seattle, Washington, USA

Facts

HQ
Seattle, Washington, USA
Sectors
Biotech
Stage
Acquired

Is this your organization? Claim it

Fundamentals for Startups: The PvP Biologics story: A molecule from concept to commercial use

(https://comotion.uw.edu) Dr. Ingrid Swanson Pultz described the founding and spinning out of her company, PvP Biologics, from the UW's Institute for Protein Design and its eventual acquisition by Takeda Pharmaceuticals. She discussed the key points that led to the success of PvP and described the challenges encountered throughout their journey. Dr. Ingrid Swanson Pultz is Chief Technology Officer at Mopac Biologics and a Translational Advisor at the Institute for Protein Design (IPD). She was Chief Scientific Officer of PvP Biologics, an IPD spin out company acquired by Takeda Pharmaceuticals in 2020, and served as the CEO for PvP in its…